Is a
Patent attributes
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
May 16, 2017
Patent Application Number
15049890
Date Filed
February 22, 2016
Patent Citations Received
Patent Primary Examiner
Patent abstract
Compositions and methods for treating macular degeneration and other forms of retinal disease whose etiology involves the accumulation of A2E and/or lipofuscin, and, more specifically, for preventing the formation and/or accumulation of A2E are disclosed.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
